Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?

By Yahoo! Finance | Nov 21, 2024 at 05:13 PM EST

The biotech industry faced volatility in 2024 with a slowdown in M&A deals despite the federal interest rate cut. Analysts were uncertain about the impact, but small-cap stocks gained momentum post the rate decrease, hinting at positive prospects for the sector.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.